(3R,4S)-4-(4-chlorophenyl)pyrrolidine-3-carboxylic acid, 98%, 250mg

TERT-BUTYL 4-TERT-BUTOXY-3-NITROBENZOATE, 95.0%, 1g

Diethyl 2-(tert-Butoxycarbonylamino)malonate, 95.0%, 1g

Cyclohexanol, min. 99%, for synthesis, 2.5 L, glass packaging

1,3-dimethyl-1,3-dihydro-2H-benzimidazol-2-one, 95.0%, 250mg

3-((1-Oxo-1,2-dihydroisoquinolin-3-yl)amino)benzoic acid, 98%, 1g

SULFASALAZINE, 97%, 10g

Glass thermometer with temperature brake Bottle filling medium, ethylene glycol mixture, -25 to -5 °C, 0.1 °C, 0.2 °C, 235 mm

1,3-Cyclohexanediamine (cis- and trans- mixture)>95.0%(GC)(T)5mL

6-Bromo-8-fluoro-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 250mg

1-cyclohexyl-2,3-dihydro-1H-imidazole-2-thione, 98%, 250mg

(6-Methyl-1,2,4,5-tetrazin-3-yl)methanamine hydrochloride, 100mg

Methyl 5-nitrothiophene-3-carboxylate, 95+%, 500mg